Clinical Trial Update: Oral Steroids for Regorafenib-induced Fatigue/Malaise in Unresectable mCRC (KSCC1402/HGCSG1402) [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating oral steroids to manage fatigue/malaise induced by regorafenib in unresectable metastatic colorectal cancer, including rectal ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Rectal Cancer

Drugs mentioned

• Oral Corticosteroids
• Regorafenib (regorafenib)

Snippet

Sponsor: Clinical Research Support Center Kyush | Conditions: Rectal Cancer | Phase 2 | Status: UNKNOWN